Friday 10 February 2012

Lupin launches Generic Diabetes drug


Indian pharmaceutical major Lupin launched the generic version of Watson's Fortamet despite an impeding patent suit against Lupin in the US.
The branded product's generic name is metformin ER, used to improve glycemic control in adults with type II diabetes which is usually associated with lifestyle. Annual sales of Fortamet are around $90 million. Lupin also has a firstto-file status on its application with the US Food and Drug Administration (FDA) for the drug, which will give the company an exclusive period to sell the drug for 180 days after the litigation, is settled.

No comments:

Post a Comment